Gene: CBLN1
Official Full Name: cerebellin 1 precursorprovided by HGNC
Gene Summary: This gene encodes a cerebellum-specific precursor protein, precerebellin, with similarity to the globular (non-collagen-like) domain of complement component C1qB. Precerebellin is processed to give rise to several derivatives, including the hexadecapeptide, cerebellin, which is highly enriched in postsynaptic structures of Purkinje cells. Cerebellin has also been found in human and rat adrenals, where it has been shown to enhance the secretory activity of this gland. [provided by RefSeq, Aug 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38666 | CBLN1 Knockout cell line (HEK293) | Human | CBLN1 | 1:3~1:6 | Negative | Online Inquiry |
CBLN1 Gene Knockout Cell Lines are genetically modified cell lines designed to study the role and function of the CBLN1 gene, which encodes for the protein cerebellin-1. This gene plays a critical role in synapse formation and neuronal signaling in the central nervous system. By creating knockout models, researchers can effectively elucidate the pathways and biological processes influenced by CBLN1, providing valuable insights into various neurological disorders.
The primary function of CBLN1 Gene Knockout Cell Lines is to facilitate the investigation of cerebellin-1’s involvement in synaptic connectivity and its potential implications in diseases such as autism, schizophrenia, and ataxia. These cell lines employ CRISPR/Cas9 technology for specific gene disruption, allowing scientists to manipulate the CBLN1 gene accurately. The absence of this protein not only enables the study of compensatory mechanisms in neuronal networks but also aids in exploring novel therapeutic targets.
The scientific importance of these knockout cell lines extends beyond basic research. In translational settings, they can support the development of targeted gene therapies and biologics, addressing complex neurological conditions. Researchers aiming to understand the pathophysiology tied to CBLN1 can leverage these models to uncover potential biomarkers for disease progression and therapeutic response.
Compared to conventional wild-type cell lines, CBLN1 Gene Knockout Cell Lines offer distinct advantages, including the ability to model specific genetic mutations, reduced background noise from non-target effects, and enhanced reproducibility of experimental results. The precision of CRISPR/Cas9 technology ensures that users are equipped with consistent models tailored for high-quality scientific investigation.
Investing in CBLN1 Gene Knockout Cell Lines empowers researchers and clinicians to harness the specificity of gene knockout technology to advance knowledge in neurological research. Our company prides itself on its extensive expertise in cellular technologies and genetic engineering, ensuring that each product meets the highest standards of quality and reliability for impactful scientific exploration.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.